FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive adjusted... The post FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment appeared first on Kosmo Digital.


2 w.
Economics
ID: -5143838087571113858


Similar News expand_more


Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Technology
Economics
Economics
Travel
Economics
Technology
Economics
Education
Technology
Travel
Economics
Economics
Automotive
Economics
Economics
Sport
Sport
Economics
Technology
Economics
Travel
Economics
Economics
Technology
Travel
Economics
Technology
Economics
Weather
Travel
Economics
Technology
Economics
Economics
Economics
Economics
Technology
Economics
Space
Economics
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down